SPRC Stock Analysis: Buy, Sell, or Hold?
SPRC - SciSparc Ltd. Ordinary Shares
$1.20
-0.14 (-10.45%)
βΌ
5d:
-40.0%
30d:
-76.05%
90d:
-77.49%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When SPRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: SPRC is down 40.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: SPRC is down 40.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SPRC is currently trading at $1.20, which is considered oversold relative to its 30-day fair value range of $2.65 to $5.25.
Technical Outlook: Technically, SPRC is in a downtrend. The price is currently testing key support at $1.18. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.4% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SPRC is in a downtrend. The price is currently testing key support at $1.18. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.4% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.65 -
$5.25
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
68.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BEARISH: Downward momentum (-10.4%)
- WARNING: Composite score 50/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.65 -
$5.25
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.18
Resistance Level
$5.33
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Revenue Growth (YoY)
-38.4%
Share & Embed Analysis
Last updated: October 22, 2026 2:56 PM ET
Data refreshes hourly during market hours. Next update: 3:56 PM
Data refreshes hourly during market hours. Next update: 3:56 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SPRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRAX
Praxis Precision Medicin⦠|
STRONG BUY
20 analysts |
$650 | 61 BUY |
|
DYN
Dyne TherapeuticsΒ Inc |
STRONG BUY
17 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I⦠|
STRONG BUY
20 analysts |
$31 | 66 BUY |
|
IMUX
Immunic Inc |
STRONG BUY
12 analysts |
$43 | 70 BUY |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 60 BUY |